We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Unveils Compromise Language for Biosimilar Substitution Laws
GPhA Unveils Compromise Language for Biosimilar Substitution Laws
GPhA is pushing for more states to pass automatic biosimilar substitution laws next year using draft language that eliminates requirements to notify prescribers of a swap with the brand.